Methicillin‐Resistant <i>Staphylococcus aureus</i>: A Public Health Issue with Economic Consequences

Mireille Goetghebeur, Pierre‐Alexandre Landry, Donald Han, +1

Canadian Journal of Infectious Diseases and Medical Microbiology

Economic burden of nausea and vomiting of pregnancy in the USA.

Charles Piwko, Gideon Koren, Vusal Babashov, +2

PubMed

Cost of Glaucoma in Canada: Analyses Based on Visual Field and Physician's Assessment

Michaël Iskedjian, John Walker, Colin Vicente, +4

Journal of Glaucoma

Economic evaluation of Avonex® (interferon beta-1a) in patients following a single demyelinating event

Michaël Iskedjian, John H. Walker, Trevor A. Gray, +3

Multiple Sclerosis Journal

The cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis in Canada

Wenqing Su, Colin Vicente, Baris Deniz, +1

Journal of Medical Economics

Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden

Thomas R. Einarson, Colin Vicente, Roman Zilbershtein, +5

Nordic Journal of Psychiatry

Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece

Thomas R. Einarson, Maria Geitona, A Chaidemenos, +12

Annals of General Psychiatry

Quality assessment of meta-analyses of RCTs of pharmacotherapy in major depressive disorder

M. Hemels, Colin Vicente, Hamid Sadri, +2

Current Medical Research and Opinion

Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension

Lutchmie Narine, L. Kathleen Hague, John H. Walker, +5

Current Medical Research and Opinion

The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada

Mohsen Sadatsafavi, J. Mark FitzGerald, Paul M. O’Byrne, +4

Allergy Asthma and Clinical Immunology